98 related articles for article (PubMed ID: 26526849)
1. Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening.
Norn C; Hauge M; Engelstoft MS; Kim SH; Lehmann J; Jones RM; Schwartz TW; Frimurer TM
Structure; 2015 Dec; 23(12):2377-2386. PubMed ID: 26526849
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.
Engelstoft MS; Norn C; Hauge M; Holliday ND; Elster L; Lehmann J; Jones RM; Frimurer TM; Schwartz TW
Br J Pharmacol; 2014 Dec; 171(24):5774-89. PubMed ID: 25117266
[TBL] [Abstract][Full Text] [Related]
3. Parameterization of the GPR119 Receptor Agonist AR231453.
Hamilton J; Kotsikorou E
J Comput Chem; 2018 Jan; 39(1):35-41. PubMed ID: 29023843
[TBL] [Abstract][Full Text] [Related]
4. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
[TBL] [Abstract][Full Text] [Related]
5. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
[TBL] [Abstract][Full Text] [Related]
6. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
7. The first pharmacophore model for potent G protein-coupled receptor 119 agonist.
Zhu X; Huang D; Lan X; Tang C; Zhu Y; Han J; Huang W; Qian H
Eur J Med Chem; 2011 Jul; 46(7):2901-7. PubMed ID: 21524831
[TBL] [Abstract][Full Text] [Related]
8. Identification of new potent GPR119 agonists by combining virtual screening and combinatorial chemistry.
Wellenzohn B; Lessel U; Beller A; Isambert T; Hoenke C; Nosse B
J Med Chem; 2012 Dec; 55(24):11031-41. PubMed ID: 23211099
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
10. APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice.
Bahirat UA; Shenoy RR; Goel RN; Nemmani KV
Eur J Pharmacol; 2017 Apr; 801():35-45. PubMed ID: 28274625
[TBL] [Abstract][Full Text] [Related]
11. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
12. Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control.
Semple G; Ren A; Fioravanti B; Pereira G; Calderon I; Choi K; Xiong Y; Shin YJ; Gharbaoui T; Sage CR; Morgan M; Xing C; Chu ZL; Leonard JN; Grottick AJ; Al-Shamma H; Liang Y; Demarest KT; Jones RM
Bioorg Med Chem Lett; 2011 May; 21(10):3134-41. PubMed ID: 21444206
[TBL] [Abstract][Full Text] [Related]
13. Modeling G protein-coupled receptors for structure-based drug discovery using low-frequency normal modes for refinement of homology models: application to H3 antagonists.
Rai BK; Tawa GJ; Katz AH; Humblet C
Proteins; 2010 Feb; 78(2):457-73. PubMed ID: 19787776
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening.
Sindhu T; Srinivasan P
Mol Biosyst; 2015 May; 11(5):1305-18. PubMed ID: 25787676
[TBL] [Abstract][Full Text] [Related]
15. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
16. GPCR profiling: from hits to leads and from genotype to phenotype.
Cvijic ME; Sum CS; Alt A; Zhang L
Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
[TBL] [Abstract][Full Text] [Related]
17. Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.
Scott JS; Birch AM; Brocklehurst KJ; Broo A; Brown HS; Butlin RJ; Clarke DS; Davidsson O; Ertan A; Goldberg K; Groombridge SD; Hudson JA; Laber D; Leach AG; Macfaul PA; McKerrecher D; Pickup A; Schofield P; Svensson PH; Sörme P; Teague J
J Med Chem; 2012 Jun; 55(11):5361-79. PubMed ID: 22545772
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists.
Wang Y; Yu M; Zhu J; Zhang JK; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Liu JJ; Coward P
Bioorg Med Chem Lett; 2014 Feb; 24(4):1133-7. PubMed ID: 24440299
[TBL] [Abstract][Full Text] [Related]
19. Molecular interaction fingerprint approaches for GPCR drug discovery.
Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
[TBL] [Abstract][Full Text] [Related]
20. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening.
Kołaczkowski M; Bucki A; Feder M; Pawłowski M
J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
